U.S. Senator Alex Padilla visited UC Irvine on September 8 to examine how university research contributes to improving public health, drives innovation, and supports the development of new treatments for Alzheimer’s disease and other forms of dementia. The visit included meetings with campus leaders, who provided presentations on UC Irvine’s comprehensive research portfolio, UCI Health, Beall Applied Innovation, and UCI MIND. Senator Padilla also toured a laboratory at UCI MIND, which is UC Irvine’s interdisciplinary research center focused on understanding, diagnosing, treating, and preventing Alzheimer’s disease and other forms of dementia.
Senator Padilla emphasized the critical role of federal funding in university research across the nation, stating it helps shape the future of health and technology. He noted this is particularly evident at the UCI MIND laboratory, where researchers are advancing “life-saving medical breakthroughs.” Padilla expressed honor in meeting UCI Health researchers to understand their work supporting patients and families affected by dementia and how Congress can assist in funding impactful research.
Aileen Anderson, the vice chancellor for research, highlighted the necessity of consistent federal investment in university research. Anderson explained that unpredictable funding streams complicate the ability to maintain research laboratories, support ongoing programs, and create opportunities for students. She also pointed out that academic research centers are vital for translating basic research discoveries through clinical trials and ultimately delivering them to patients. Anderson later affirmed the university's appreciation for the opportunity to showcase its research efforts to Senator Padilla.
Dr. Michael Stamos, who serves as interim vice chancellor for health affairs and dean of the School of Medicine, detailed the expansion of UCI Health’s network of hospitals and clinics. He also discussed UC Irvine’s four health sciences schools: medicine, nursing, pharmacy, and public health. Stamos explained that robust translational and clinical research conducted within these areas is directly contributing to new discoveries, products, treatments, and cures. Furthermore, this research is preparing the next generation of healthcare professionals.
Errol Arkilic, UC Irvine’s chief innovation officer, presented on the university's established infrastructure designed to transform research discoveries into marketable products and services. Arkilic described the university's efforts to facilitate the movement of innovations from the laboratory setting to the commercial marketplace. These innovations span various fields, including medical devices, artificial intelligence, aerospace, and national security. He cited specific examples of UC Irvine technologies that are progressing toward commercialization.
Joshua Grill, director of UCI MIND, offered an update on advancements in Alzheimer’s research. His presentation included details on new techniques such as PET imaging and blood-based testing, alongside emerging treatments. Grill also spoke about ongoing initiatives to increase participation from the Latino community in clinical trials for Alzheimer's disease.
The visit provided UC Irvine with an occasion to demonstrate how the research conducted at public universities can directly enhance the health and overall quality of life for residents. Vice Chancellor Anderson reiterated the university’s gratitude for the Senator’s engagement with researchers and his interest in the contributions of public research universities to health and quality of life. The discussions underscored the local impact of federally supported research carried out within Irvine’s university community.
